Patent linkages allow the connection of marketing approvals (MA) for generic pharma products to the patents covering an innovator company’s original/reference drug. Their purpose is to ensure that MAs are not given to patented products; and to allow generic makers to plan their launches without infringement risk, and also to invalidate weak patents.
Full article by Nick Redfearn for Rouse Magazine: https://www.rouse.com/magazine/news/patent-linkages-in-se-asia/?tag=ip%20komodo